BRD7P6

Across TCGA pan-cancer cohorts, BRD7P6 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of BRD7P6’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where BRD7P6 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BRD7P6 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

HNSC, BRCA, and LUSC are the cancer types where BRD7P6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BRD7P6 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	II,III,IV	+0.043	<.001	10	view →
BRCA	All	All	−0.009	.003	4	view →
LUSC	All	All	+0.054	.006	3	view →
LUAD	Female	All	+0.007	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

BRD7P6–HNSC

Open the HNSC breakdown →